Researchers develop technology for real-time monitoring of Parkinson's treatments
Sungkyunkwan University researchers have developed a biochip technology that enables real-time monitoring of Parkinson’s disease treatment responses. The university said Tuesday that the “organoid-on-a-chip” technology combines stem cell-derived “mini-brains” with a nanoplasmonic sensor that maximizes light-matter interactions, enabling real-time monitoring of treatment responses. The findings…
Researchers at Sungkyunkwan University have created a groundbreaking biochip technology designed to monitor Parkinson's disease treatment responses in real-time. This innovative "organoid-on-a-chip" combines stem cell-derived mini-brains with a nanoplasmonic sensor that enhances light-matter interactions, allowing for continuous tracking of treatment effects.
The findings, published in ACS Nano, a top international journal in nanoscience, resulted from the collaborative efforts of two research teams, each led by professors Kim In-ki and Park Jong-chan. The teams included Ph.D. candidates Cho Han-jun and Kim Young-jun, as well as master’s candidate Yoon Na-hyun, who together authored the publication.
Professor Kim highlighted the study's significance, stating that it enables ongoing monitoring of drug responses using an ultra-precise optical sensor within living human tissue over time. The university aims to further develop this technology as a platform for patient-specific drug development and disease treatment.
Written by urgent.news from The Korea Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
